What was the overall market valuation of the US diabetes monitors market in 2024?

The overall market valuation was $2915.5 Million in 2024. Read More

What is the projected market valuation for the US diabetes monitors market by 2035?

The projected valuation for 2035 is $5387.06 Million. Read More

What is the expected CAGR for the US diabetes monitors market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period is 5.74%. Read More

Which company is a key player in the US diabetes monitors market?

Key players include Abbott (US), Roche (CH), and Dexcom (US), among others. Read More

What were the revenue figures for Blood Glucose Monitors in 2024?

The revenue for Blood Glucose Monitors was between $1200.0 Million and $2200.0 Million in 2024. Read More

How much is the market for Continuous Glucose Monitors expected to grow by 2035?

The market for Continuous Glucose Monitors is projected to grow from $1000.0 Million to $1800.0 Million by 2035. Read More

What is the revenue range for Type 2 Diabetes Management in 2024?

The revenue range for Type 2 Diabetes Management was between $1800.0 Million and $3200.0 Million in 2024. Read More

What segment had the highest revenue in the US diabetes monitors market in 2024?

The segment with the highest revenue was Type 2 Diabetes Management, with figures reaching up to $3200.0 Million. Read More

What is the projected revenue for Wearable Monitors by 2035?

The projected revenue for Wearable Monitors is expected to reach between $215.5 Million and $487.06 Million by 2035. Read More

What technology segment is anticipated to see significant growth in the US diabetes monitors market?

The Strip-Based Technology segment is anticipated to grow from $1000.0 Million to $1800.0 Million by 2035. Read More

US Diabetes Monitors Market

ID: MRFR/MED/13123-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Diabetes Monitors Market Research Report By Device Type (Blood Glucose Monitors, Continuous Glucose Monitors, Smartphone Integrated Monitors, Wearable Monitors), By Technology (Strip-Based Technology, Electrochemical Technology, Enzymatic Technology, Non-Invasive Technology), By Application (Type 1 Diabetes Management, Type 2 Diabetes Management, Gestational Diabetes Management) and By End Use (Home Care, Hospital Care, Diagnostic Laboratories) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Device Type (USD Million)
  1. 4.1.1 Blood Glucose Monitors
  2. 4.1.2 Continuous Glucose Monitors
  3. 4.1.3 Smartphone Integrated Monitors
  4. 4.1.4 Wearable Monitors
2. 4.2 Construction, BY Technology (USD Million)
  1. 4.2.1 Strip-Based Technology
  2. 4.2.2 Electrochemical Technology
  3. 4.2.3 Enzymatic Technology
  4. 4.2.4 Non-Invasive Technology
3. 4.3 Construction, BY Application (USD Million)
  1. 4.3.1 Type 1 Diabetes Management
  2. 4.3.2 Type 2 Diabetes Management
  3. 4.3.3 Gestational Diabetes Management
4. 4.4 Construction, BY End Use (USD Million)
  1. 4.4.1 Home Care
  2. 4.4.2 Hospital Care
  3. 4.4.3 Diagnostic Laboratories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Dexcom (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bayer (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Ascensia Diabetes Care (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Terumo (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GlucoRx (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Insulet (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY DEVICE TYPE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY END USE, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Construction Market Segmentation

Construction By Device Type (USD Million, 2025-2035)

Blood Glucose Monitors
Continuous Glucose Monitors
Smartphone Integrated Monitors
Wearable Monitors

Construction By Technology (USD Million, 2025-2035)

Strip-Based Technology
Electrochemical Technology
Enzymatic Technology
Non-Invasive Technology

Construction By Application (USD Million, 2025-2035)

Type 1 Diabetes Management
Type 2 Diabetes Management
Gestational Diabetes Management

Construction By End Use (USD Million, 2025-2035)

Home Care
Hospital Care
Diagnostic Laboratories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”